Oticon More vs Otofonix Encore

The Oticon More is a premium behind-the-ear prescription hearing aid that earned an A grade with a SoundScore of 4.6/5 in our lab testing, placing it in the top 22% of the 36 prescription hearing aids we've evaluated. Released in 2021, this device remains competitive and has received HearAdvisor's Expert's Choice Award in both 2023 and 2024. In our testing, the Oticon More demonstrated strong speech clarity performance. Speech in quiet scored 4.0/5, which is 0.73 points above the category average—a notable margin that reflects genuine audibility advantages in everyday conversations. Speech in noise measured 2.7/5, which is above the category average by 0.75 points, though only mixed in absolute terms, meaning challenging listening environments may still require effort. Own-voice comfort scored a solid 3.1/5 (+0.35 vs category average), and music streaming measured 3.0/5 (+0.36 vs category average), both performing above typical prescription aids. Feedback handling scored 3.5/5, which is solid in absolute terms, though below the category average of 4.71/5 by 1.21 points—something to discuss with your hearing care provider. At $4,598, this is a premium-priced device offering iPhone and Android streaming, hands-free calling, and your choice of rechargeable or disposable batteries. The Oticon More is well-suited for those prioritizing speech clarity who want a proven performer from an established manufacturer. Competitors in this price range include the newer Oticon Intent (4.85/5) and Oticon Real (4.75/5), which may be worth comparing during your fitting appointment.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.